Stock PNVL3 DIMED S.A. DISTRIBUIDORA DE MEDICAMENTOS
Add to a list
To use this feature you must be a member
Log inSign up

Ratings Dimed S.A. Distribuidora de Medicamentos

Equities

PNVL3

BRPNVLACNOR9

Market Closed - Sao Paulo
Other stock markets
 04:07:56 2024-05-03 pm EDT 		5-day change 1st Jan Change
11.51 BRL +3.69% Intraday chart for Dimed S.A. Distribuidora de Medicamentos +2.68% -13.85%
Mar. 14 Dimed S.A. Distribuidora de Medicamentos Reports Earnings Results for the Full Year Ended December 31, 2023 CI
2023 Dimed S.A. Distribuidora de Medicamentos Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI

Summary

  • The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.

Strengths

  • The company's earnings per share (EPS) are expected to grow significantly over the next few years according to the consensus of analysts covering the stock.
  • The equity is one of the most attractive in the market with regard to earnings multiple-based valuation.
  • The company is one of the most undervalued, with an "enterprise value to sales" ratio at 0.39 for the 2024 fiscal year.
  • This company will be of major interest to investors in search of a high dividend stock.
  • The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.

Weaknesses

  • As a percentage of sales and without taking into account depreciation and amortization, the company has relatively low margins.
  • Over the past twelve months, analysts' consensus has been significantly revised downwards.
  • The price targets of analysts who cover the stock differ significantly. This implies difficulties in evaluating the company and its business.
  • Financial statements have repeatedly disappointed market stakeholders. Most often, they were below expectations.

Ratings chart - Surperformance

Sector: Drug Retailers

1st Jan change Capi. Investor Rating ESG Refinitiv
DIMED S.A. DISTRIBUIDORA DE MEDICAMENTOS Stock Dimed S.A. Distribuidora de Medicamentos
-13.85% 338M -
WALGREENS BOOTS ALLIANCE, INC. Stock Walgreens Boots Alliance, Inc.
-31.79% 15.36B
B-
JD HEALTH INTERNATIONAL INC. Stock JD Health International Inc.
-21.99% 12.45B
B
ALIBABA HEALTH INFORMATION TECHNOLOGY LIMITED Stock Alibaba Health Information Technology Limited
-22.64% 6.75B
B
YIFENG PHARMACY CHAIN CO., LTD. Stock Yifeng Pharmacy Chain Co., Ltd.
+9.74% 6.14B
C
MATSUKIYOCOCOKARA & CO. Stock MatsukiyoCocokara & Co.
-10.91% 6.07B
C+
NAHDI MEDICAL COMPANY Stock Nahdi Medical Company
+0.58% 4.78B
D-
CORPORATIVO FRAGUA, S.A.B. DE C.V. Stock Corporativo Fragua, S.A.B. de C.V.
+59.24% 4.53B -
C
CLICKS GROUP LIMITED Stock Clicks Group Limited
-9.00% 3.81B
B
DASHENLIN PHARMACEUTICAL GROUP CO., LTD. Stock DaShenLin Pharmaceutical Group Co., Ltd.
-12.53% 3.43B
C-
Investor Rating
Trading Rating
ESG Refinitiv
-

Financials

Sales growth
Earnings Growth
EBITDA / Sales
Profitability
Finances

Valuation

P/E ratio
EV / Sales
Price to Book
Price to Free Cash Flow
-
Yield

Momentum

1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision

Consensus

Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
-
12m Revision of opinion

Business Predictability

Analyst Coverage
Divergence of Estimates
-
Divergence of analysts' opinions
Divergence of Target Price
Earnings quality

Technical analysis

ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes
  1. Stock Market
  2. Equities
  3. PNVL3 Stock
  4. Ratings Dimed S.A. Distribuidora de Medicamentos